GSK4528287

Phase 1Small molecule

GSK

GSK4528287 is one of 14 small molecule programs targeting Colitis, Ulcerative. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Colitis, UlcerativeActive, not recruiting

Colitis, UlcerativePhase 1

Active, not recruiting

Competition

Competitive Landscape

17 competitors in Colitis, Ulcerative

#DrugCompanyPhaseTrials

Tremfya

Johnson & Johnson

Phase 3

4 2

Simponi

Johnson & Johnson

Phase 3

2 3

Remicade

Johnson & Johnson

Phase 3

1 4

Icotyde

Johnson & Johnson

Phase 3

1 5

Velsipity

Pfizer

Phase 2

3 6

Omvoh

Eli Lilly

Phase 2

1 7

JNJ-78934804

Johnson & Johnson

Phase 3

2 8

Dupixent

AAzienda U.S.L. 1 di Massa e Carrara

Phase 2

1 9

Guselkumab Dose 2

Johnson & Johnson

Phase 3

1 10

Guselkumab Dose 3

Johnson & Johnson

Phase 3

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2027

Phase 1Active, not recruiting

Colitis, Ulcerative

NCT06681181

Clinical

Trials by Indication[1]

Colitis, Ulcerative1 trial

A Phase 1, Randomized, Double-Blind, Placebo Controlled, Single Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Target Engagement of GSK4528287 in Healthy Participants

Active, not recruiting· GSK logo

GSK·Phase 1·NCT06681181·48 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for GSK4528287. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — GSK4528287 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for GSK4528287. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: GSK

GSK4528287

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2027

Trials by Indication[1]

Colitis, Ulcerative1 trial

References

Drug Info

Quick Facts

Related News